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Since January 2008—de facto 2012—medical physics experts (MPEs) are, by law, to be involved in the optimisation process of
radiological diagnostic procedures in Switzerland. Computed tomography, fluoroscopy and nuclear medicine imaging units have
been assessed for patient exposure and image quality. Large spreads in clinical practice have been observed. For example, the
number of scans per abdominal CT examination went from 1 to 9. Fluoroscopy units showed, for the same device settings, dose
rate variations up to a factor of 3 to 7. Quantitative image quality for positron emission tomography (PET)/CT examinations
varied significantly depending on the local image reconstruction algorithms. Future work will be focused on promoting team co-
operation between MPEs, radiologists and radiographers and on implementing task-oriented objective image quality indicators.
In 1997, the European Council Directive 97/43/
EURATOM introduced the implication of medical
physics experts (MPEs) in the optimisation process of
radiological diagnostic procedures. That recommenda-
tion has been translated into the Swiss Radiological
Protection Ordinance (RO(1)) and applied officially in
2008, de facto in 2012. This contribution summarises
the application methodology, as well as the results, after
1 y of experience. (NB: The Radiological Protection
Ordinance is usually abbreviated using RPO, but RO
will be used in this text to avoid any confusion with
‘Radiation Protection Officer’.)
INTRODUCTION
In Switzerland, the Federal Office of Public Health
(FOPH) legally authorises the manufacturer for per-
forming quality control tests of their radiological
devices. The minimal frequency, as well as the con-
tents of those periodical controls, is set by the FOPH.
The manufacturer ensures that the device runs in
accordance with the norms and criteria established by
the International Electrotechnical Commission (IEC)
standards. As a consequence, until now, the tasks of
the manufacturer were completely separated from
those of the users (physicians and radiographers).
In addition to these tests, the FOPH audits the differ-
ent radiological centres on a regular basis, in order to
ensure compliance with the national and international
safety and quality standards.
Until now, no MPE was involved in the optimisation
process in diagnostic and therapeutic radiological pro-
cedures. As such, the manufacturer is judge and jury of
the implemented clinical protocols. The authors’ aim is
to provide objective image quality assessment tools in
order to use the devices to their full potential in dose
optimisation while remaining clinically relevant. As
such:
† The manufacturer will continue to maintain the
technical integrity of the device, ensuring the link
between detector dose and image quality.
† The radiation protection expert is in charge of the
operational safety of the staff using the device.
† The MPE, in close collaboration with the physi-
cians and radiographers, will make sure that the
device is being properly used on patients, ensuring
the link between patient dose and image quality
(or, more specifically, diagnostic quality).
In opposition to several countries where MPEs are
already in place, a lot had to be done to rethink the
role of the MPE. The MPEs’ work had to yield added
value to the clinical practice without substituting the
manufacturer for the periodical technical controls.
The major part of the authors’ effort was put in the
field of computed tomography (CT), since it is the
most common diagnostic device in the vast majority of
private and public radiology practices. Furthermore,
the radiation protection requirements in interventional
radiology and nuclear medicine (NM) being more
obvious, the involvement of an MPE was much easier
in these fields.
OBJECTIVES AND METHODOLOGY
The authors will now describe the approach used for the
implementation of Article 74, Paragraph 7, of the RO.
The description, as well as the rest of this contribution,
will be separated into three imaging fields: CT, fluor-
oscopy and NM.
A common objective for those three fields was to
make an inventory of the different devices and
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technologies used by the centres in the authors’ data-
base, as well as gaining acceptance within the differ-
ent radiology institutes.
Computed tomography
The approach used for CT was focused on three axes:
† verification of the main dose indicators, since they
are used as the primary tools for protocol opti-
misation,
† benchmarking of the institutions’ image quality
using a pre-defined acquisition and reconstruction
protocol on a QA phantom,
† dosimetry assessment of the clinical use of the
devices.
Machine output
First: control of the main output parameters of the
device itself:
† volumetric computed tomography dose index
(CTDIvol), using a standard IEC 16-cm-diameter
head phantom and a 100-mm pencil ion chamber
(Radcal Corporation, Monrovia, California),
† beam collimation and penumbra, using self-
developing Gafchromic XR-CT strips,
† Hounsfield unit (HU) calibration in water at the
available X-ray tube voltages,
† laser alignment using a Catphanw 600 aligned on
the lasers, later on compared with the projection
image (topogram).
Local abdomen protocol qualification and unit
benchmarking for a given CTDIvol condition
Second: qualification of the local abdomen acquisition
and image reconstruction protocols using a standard
QA phantom (Catphanw 600, The Phantom Laboratory,
Salem, New York). Furthermore, a standard acquisi-
tion and reconstruction protocol was elaborated in
order to enable device benchmarking. Standard test
parameters were as follows:
† CTDIvol of 15 mGy, corresponding to the Swiss
diagnostic reference level (DRL) for an abdomin-
al examination,
† gantry rotation time of 1 s,
† reconstructed slice thickness of 2.5 mm (or 2 mm,
depending on the CT manufacturer and/or soft-
ware version), with contiguous slices,
† standard (soft tissue) reconstruction kernel,
† filtered back-projection, no iterative reconstruc-
tion,
† field of view (FOV) of 220 mm.
As body examinations yield the largest effective
doses(2) with the largest spread in clinical practice(3),
one of the critical aspects in diagnosis is the low-con-
trast detectability (LCD). This depends strongly on
the used dose, the reconstruction convolution kernel,
the slice thickness and the detector performance. The
three first parameters being equal, the latter could be
benchmarked. For this purpose, three observers have
looked at the images on a diagnostic screen and esti-
mated subjectively the diameter of the smallest rod
they could distinguish for a given contrast.
Clinical use of the device
Third: dosimetry analysis of a sample of clinical exami-
nations sent by the different institutions. The requested
examinations concerned standard head, chest, abdomen,
paediatric, upper- and lower-limb and cardiac acqui-
sitions. The analysed parameters were as follows:
† CTDIvol per scan,
† cumulated dose–length product (DLP), as well as
DLP per scan,
† examination effective dose E(2),
† number of scans per examination,
† measurement of the antero–posterior and lateral
(LAT) patient dimensions, to calculate the size-
specific dose estimate(4),
† used slice thicknesses,
† noise in a homogeneous zone for a given slice
thickness,
† assessment of the use of the automatic exposure
control system,
† positioning of the patient in the gantry,
† visibility check of a given list of organs by review
of the diagnostic images by an experienced radi-
ographer.
Fluoroscopy
Fluoroscopy units were characterised using the locally
implemented clinical parameters. The characterisation
was done using PMMA slabs of different thicknesses,
thus simulating patients of different sizes (Figure 1).
Dose rates measured in different sites and units were
collected and compared.
Since the dose rates of different units can differ sig-
nificantly(5), the aim was to provide the users of the unit
with a framework that showed the orders of magnitude
of their patients’ exposure by their most commonly
used clinical protocols.
No image quality measurements were performed.
However, clinical image quality requirements were ap-
parently satisfied for all systems since physicians use
those units without any preference.
Nuclear medicine
Quantitative imaging is of prime importance in NM.
Indeed, the estimation of the volumetric activity in a
lesion will yield precious information about its metab-
olism and will influence the subsequent clinical deci-
sions. This is why these aspects have to be assessed
correctly.
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Single photon emission computed tomography
For single photon emission computed tomography
(SPECT), the use of the Jaszczak (Deluxe) phantom for
overall system performance assessment is recommended
by the European Association of Nuclear Medicine
(EANM)(6), but also by the American Association of
Physicists in Medicine (AAPM) and the American
College of Radiology.
In this protocol, the phantom was filled with 400
MBq of 99mTc. Uniformity of the reconstructed
slices, cold sphere contrast and spatial resolu-
tion based on the visualisation of cold rods were
evaluated. The presence of macroscopic artefacts
was also checked by visual inspection of the recon-
structed images.
Positron emission tomography
For quantitative PET performance assessment, the
EANM promoted EARL protocol (http://earl.eanm.
org/cms/website.php?id=/en/projects/fdg_pet_ct_
accreditation.htm) was adopted as a reference. This
protocol is based on a PET/CT acquisition of the
NEMA-IEC body phantom filled with an 18F-FDG
activity concentration ratio of 10 : 1 between the hot
spheres and the background, respectively. However,
differently from the EARL protocol, the two largest
Figure 1. Schematic figure of the fluoroscopy characterisation geometry: PMMA in the primary beam, ion chamber at the
entrance point of the beam. Source-to-imaging device distance (SID): 110 cm, source-to-detector distance (SDD): 75 cm.
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spheres were filled with plain water (no activity) to
test cold contrast and, indirectly, the performance of
scatter and attenuation corrections.
CTuse in NM and feedback
Since there are currently no DRLs for the CT units
used in SPECT/CT and PET/CT, the use of CT has
to be evaluated in the scope of the different imaging
purposes. Indeed, the dose requirements are not the
same for a diagnostic scan than for the creation of a
correction attenuation map. Furthermore, the technol-
ogy employed in NM can differ from state of the art
radiologic CT (e.g. cone-beam CT or a pseudo-CT
with common gantry with the cameras). Therefore, CT
imaging in NM examinations has to be correctly assessed
based on the specific tasks to be accomplished.
For both imaging modalities (SPECT/CT and
PET/CT), the local acquisition protocols were tested,
results were discussed and a specific advice was given
in order to optimise the image acquisition and/or
reconstruction protocols to improve both qualitative
and quantitative outcomes.
Continuous education
The collected data were summarised and shared with
the users during continuous education (CE) sessions.
The aim was to update the users0 knowledge in radiation
protection, optimise the clinical use of the devices, as
well as to promote a team collaboration spirit.
RESULTS
Computed tomography
Forty-five CT units were tested in 2013 (18 % of all
CTunits in the country). Several elements were noticed.
Machine output
Four devices evidenced patient positioning laser align-
ment off by as much as 10 mm, possibly resulting in an
increase in patient dose of 6 %(7).
Nine of 45 CT units (20 %) presented a beam colli-
mation that was widely different from the value stated
by the device, e.g. 4 mm measured for 1 mm nominal.
These units took this parameter into account into their
beam efficiency calculation. For example, for a 1-mm
single-slice acquisition protocol (e.g. examination of the
posterior fossa or the petrous bone), one unit displayed
an efficiency of 14 %, thus resulting in a CTDIvol of 299
mGy, whereas a same-generation CT unit with a beam
collimation of 1.25 mm with the exact same parameters
displayed a CTDIvol of 41.5 mGy for a beam efficiency
of 55 %. Radiographers were not aware of the import-
ance of their choice of collimator settings.
Twenty-one of 45 CT units had HU in water that
were not within the legal tolerance (0 + 4 HU) for
tube voltages different from 120 or 140 kV. This was
mainly due to a lack of calibration because the ten-
sions were not used in routine. Surprisingly, even
then, an acquisition at a non-calibrated tension was
still available in user mode, thus potentially leading to
a completely erroneous examination if, for example, a
newly engaged radiologist were to perform an exam-
ination at a lower tube voltage.
Abdomen protocol qualification
The subjective estimation of the LCD performance
yielded some interesting results. For 2-mm slices, 4 of
16 CT units showed a lower detection performance,
whereas for the 2.5-mm slices, 3 of 27 CT units showed
LCD performance under the mean value. The mean
values are given in Table 1. Without clearly setting one
manufacturer apart from the others, it reminded the
users that, for the same acquisition parameters, an in-
crease in the slice thickness could lead to an increased
LCD.
However, one of the main limitations of the authors’
approach was that this was subjectively assessed, without
taking into account the spatial frequency of the noise.
Clinical use of the device
The clinical use of the devices showed a large variabil-
ity, especially for the abdominal examinations. Tables 2
and 3 and Figure 2 give an overview of this dispersion.
For example, the ratio of the 75th and 25th percentile
of the mean CTDIvol was 1.9, whereas the effective
dose showed a dispersion factor of 3.0. This shows that
the number of scans per examination is not uniform.
In 2008, the FOPH estimated the mean effective dose
for abdominal examinations at 9 mSv. The current
analysis shows a value of 18.7 + 12.7 mSv, more than
twice the last value (Figure 2 and Table 2). Reasons for
this could be a miscalculation of the 2008 value, a quick
increase in the number of scans per examination during
this period or a biased selection of the examinations.
One critical aspect is that, among CT users—and
MPEs—the concept of DRL is not clear, especially
since the number of scans is not standardised. The
current approach allowed for a clarification of the
Table 1. LCD performance for the unit benchmarking
protocol.
Slice thickness
[mm]
LCD@0.5 %
[mm]
LCD@0.3 %
[mm]
2 9.6+2.8 14.5+1.7
2.5 8.0+0.6 14.0+2.3
LCD performance is given in terms of the average smallest
low-contrast insert detected, for a given native contrast (0.5
or 0.3 %).
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actual patient exposure, thus triggering discussions
among radiologists in order to limit the dispersion of
the practice.
A further limitation was the collection of clinical cases
on the basis of anatomical regions. Thus, a bias was
introduced by comparing examinations for obviously
different clinical demands. An effort will be placed
upon analysing clinical practice with respect to
demand in the coming years.
Fluoroscopy
For approximately the same clinical settings, the dose
rates showed large variations. For example, when
putting 20 cm of PMMA in the primary beam, acqui-
sitions at 15 frames per second (typical for interven-
tional cardiology procedures) had differences up to a
factor 3 (Figure 3). Measurements made with diag-
nostic settings (cineradiography or digital subtraction
angiography) even yielded differences up to a factor 7.
Nuclear medicine
The analysis of early results obtained from a few tested
devices showed heterogeneous PET performance. The
main factor for differences was the availability or not of
time-of-flight and point spread function corrections
that strongly impact both overall image noise and
activity recovery in small-sized lesions.
Furthermore, although the radiographers practis-
ing SPECT/CT and/or PET/CT examinations were
fairly aware of the principles of radiation protection
when manipulating radioactive sources, they were not
comfortable with the interpretation of the CT dose
indicators, as there are still no existing DRLs specific-
ally for transmission imaging in NM.
Continuous education
Approximately 150 radiographers have participated
into 7 CE sessions organised throughout the year. The
lecture’s themes were a description of the methodology
Table 3. Dispersion of the clinical use in terms of the percentile of abdomen dose indicators.
Percentile Mean CTDIvol [mGy] Mean DLP [mGy cm] Cumulated DLP [mGy cm] No. of phases E [mSv]
25th 8.0 320 550 1 8.4
75th 14.8 665 1655 3 25.4
75th/25th 1.9 2.1 3.0 3 3.0
The dispersion of the practice is given by the ratio between the 75th percentile and the 25th percentile of the distribution, thus
ignoring the extreme values.
Table 2. Mean values of the main dose indicators for clinical use of CT units, along with the measured ranges.
Protocol Mean CTDIvol [mGy] Mean DLP [mGy cm] No. of phases E [mSv]
Head 51.2+13.9
22.1–84.2
905+275
286–1812
1.7+0.7
1–4
3.2+1.3
1.0–6.6
Chest 8.5+5.5
2.6–31.8
310+165
96–816
1.4+0.5
1–3
6.2+3.5
1.4–20.3
Abdomen 12.2+7.0
2.6–48.8
535+320
96–2085
2.4+1.3
1–9
18.7+12.7
2.0–112.0
Mean CTDIvol and DLP are given per scan, whereas the effective dose and number of scans are given per examination.
Figure 2. Dispersion of the clinical use of CT for abdominal
examinations in terms of effective dose per examination. The
2008 value from the FOPH dose estimation is given as a
comparison.
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used in CT qualification within the new legal frame-
work and a reminder of the dose indicators as well as
the metrics of image quality with respect to dose. One
important aspect was the gain of confidence between
the radiographers and the MPE.
PERSPECTIVES
For CT, the future tasks are divided into two subsets.
First, there is a strong need for an objective qualifica-
tion of LCD, so the user is aware of the potential loss
in LCD performance when using low-dose protocols
along with iterative image reconstruction algorithms.
Second, the sampling of examinations is to become
task-oriented rather than relative to a given anatomical
region. The ultimate goal would be to have one (or
several) objective image quality indicator(s) for a given
clinical demand. For example, the search of kidney
stones (high contrast) does not need the same dose
level than a suspected liver carcinoma. For this, the im-
plementation of model observers on anthropomorphic
systems is a promising tool towards this solution.
For fluoroscopy, a great deal of effort has been put
into the establishment of new reference levels in inter-
ventional cardiology. For this purpose, automated
dose collection software will become of prime import-
ance. Nonetheless, a crucial point that has yet not been
investigated thoroughly is the reliability of the dose
indicators of the devices, such as cumulative dose or
cumulative dose–area product. Indeed, the former is
defined at two different locations in the beam (FDA or
IEC reference points); the latter, especially since diag-
nostic beams are heavily filtered using copper, is, based
on preliminary measurements, potentially off by a
factor of 2. A new investigation protocol to address this
problem is currently being set up by the AAPM task
group 190, and their final report is due in December
2014. As a consequence, the traceability of the testing
instruments will be even more important, and the toler-
ance on dose indicators will have to be lowered.
Furthermore, the nomenclature of the specific diagnos-
tic and/or therapeutic interventions is not unified, thus
making a proper large-scale dose collection tedious.
Interventional cardiology, for which soon-to-be
published DRL have been established (as cited previ-
ously), could serve as a role model for this task. An
effort will also be taken on the establishment of a
database of objective image quality indicators for
parameters deemed acceptable by physicians after
optimisation.
Finally, for NM, two aspects seem to emerge from
the first results. First, a great deal of effort has to be put
into the calibration of the individual activity meters of
the different institutions, by using a solid 68Ga/68Ge
phantom for PET and the Jaszczak phantom for
SPECT. Second, the use of CT for attenuation correc-
tion will, as for conventional CT, benefit of the model
observer routines to tackle objective image quality.
The CE sessions have allowed the MPE to gain
knowledge of the devices across the country and confi-
dence with respect to their clinical applications. The next
step will be to establish partnerships with radiologists.
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